DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Bicnu is a drug marketed by Emcure Pharms Ltd and is included in one NDA.
The generic ingredient in BICNU is carmustine. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the carmustine profile page.
A generic version of BICNU was approved as carmustine by NAVINTA LLC on September 11th, 2018.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Emcure Pharms Ltd||BICNU||carmustine||INJECTABLE;INJECTION||017422-001||Approved Prior to Jan 1, 1982||AP||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|